Valeant Specialty Pharmacy

Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) were trading lower by nearly 2 percent early morning after the company released its delayed 10-k filing which includes its first quarter results. Valeant reported it lost $1.12 per share in the first quarter on revenue of $2.76 billion....